Patents by Inventor Albert BARTA

Albert BARTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20220193045
    Abstract: The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: March 4, 2022
    Publication date: June 23, 2022
    Inventors: Wolfram EISENREICH, Nadia S. LADYZHYNSKY, Danping LI, Leon SCHULTZ, Zeren WANG, Sreeraj MACHA, Albert BARTA
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20180289678
    Abstract: The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 11, 2018
    Inventors: Wolfram EISENREICH, Nadia S. LADYZHYNSKY, Danping LI, Leon SCHULTZ, Zeren WANG, Sreeraj MACHA, Albert BARTA
  • Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
    Patent number: 10004743
    Abstract: The present invention relates to a drying process of BIBW 2992 or the salts thereof, preferably the dimaleate salt, as well as of solid pharmaceutical formulations comprising BIBW2992 or a salt thereof, and to pharmaceutical compositions comprising BIBW 2992 or a salt thereof as the active product ingredient, characterized by a water activity of the formulation of not more than 0.20 or a water content (Karl-Fischer) of not more than 4.2%.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: June 26, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventor: Albert Barta
  • PROCESS FOR DRYING OF BIBW2992, OF ITS SALTS AND OF SOLID PHARMACEUTICAL FORMULATIONS COMPRISING THIS ACTIVE INGREDIENT
    Publication number: 20170079980
    Abstract: The present invention relates to a drying process of BIBW 2992 or the salts thereof, preferably the dimaleate salt, as well as of solid pharmaceutical formulations comprising BIBW2992 or a salt thereof, and to pharmaceutical compositions comprising BIBW 2992 or a salt thereof as the active product ingredient, characterized by a water activity of the formulation of not more than 0.20 or a water content (Karl-Fischer) of not more than 4.2%.
    Type: Application
    Filed: December 7, 2016
    Publication date: March 23, 2017
    Inventor: Albert BARTA
  • Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
    Patent number: 9545381
    Abstract: The present invention relates to a drying process of BIBW 2992 or the salts thereof, preferably the dimaleate salt, as well as of solid pharmaceutical formulations comprising BIBW2992 or a salt thereof, and to pharmaceutical compositions comprising BIBW 2992 or a salt thereof as the active product ingredient, characterized by a water activity of the formulation of not more than 0.20 or a water content (Karl-Fischer) of not more than 4.2%.
    Type: Grant
    Filed: July 5, 2010
    Date of Patent: January 17, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventor: Albert Barta
  • PROCESS FOR DRYING OF BIBW2992, OF ITS SALTS AND OF SOLID PHARMACEUTICAL FORMULATIONS COMPRISING THIS ACTIVE INGREDIENT
    Publication number: 20120107399
    Abstract: The present invention relates to a drying process of BIBW 2992 or the salts thereof, preferably the dimaleate salt, as well as of solid pharmaceutical formulations comprising BIBW2992 or a salt thereof, and to pharmaceutical compositions comprising BIBW 2992 or a salt thereof as the active product ingredient, characterized by a water activity of the formulation of not more than 0.20 or a water content (Karl-Fischer) of not more than 4.2%.
    Type: Application
    Filed: July 5, 2010
    Publication date: May 3, 2012
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventor: Albert Barta
  • PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20110014284
    Abstract: The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.
    Type: Application
    Filed: February 11, 2010
    Publication date: January 20, 2011
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Wolfram EISENREICH, Nadia S. LADYZHYNSKY, Danping LI, Leon SCHULTZ, Zeren WANG, Sreeraj MACHA, Albert BARTA